Icon price target lowered to $255 from $270 at BofA
BofA analyst Michael Ryskin lowered the firm’s price target on Icon (ICLR) to $255 from $270 and keeps a Buy rating on the shares. The firm ...
J.P. Morgan Sticks to Their Buy Rating for Icon (ICLR)
J.P. Morgan analyst Casey Woodring maintained a Buy rating on Icon (ICLR – Research Report) on February 1 and set a price target of $265.00.
TD Cowen cuts ICON stock price target to $254, maintains Buy rating
TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.